Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes

J. P. Rasanen, C. K. Snyder, P. V. Rao, R. Mihalache, S. Heinonen, M. G. Gravett, C. T. Roberts, S. R. Nagalla

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)S68
JournalDiabetes Technology and Therapeutics
Volume17
DOIs
StatePublished - Feb 1 2015

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this

Rasanen, J. P., Snyder, C. K., Rao, P. V., Mihalache, R., Heinonen, S., Gravett, M. G., Roberts, C. T., & Nagalla, S. R. (2015). Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes. Diabetes Technology and Therapeutics, 17, S68. https://doi.org/10.1089/dia.2015.1508